Interestingly, Terry et al.(2007) and Merritt et al.(2013) reported a potential association between ovarian cancer risk and geneticvariations influencing caffeine metabolism, particularly within the CYP1A1 and CYP1A2 genesencoding cytochrome P450 enzymes responsible for caffeine breakdown. This evidence concerns the gene CYP1A2 and ovarian carcinoma.